Carb Starver

Carb Starver is a biotechnology and nutraceutical company focused on developing metabolic health solutions that modulate carbohydrate absorption. The company's primary product is a proprietary formulation designed to inhibit digestive enzymes such as alpha-amylase and alpha-glucosidase, thereby reducing the glycemic impact of dietary starches. By slowing the breakdown of complex carbohydrates into simple sugars, the company aims to assist in the management of blood glucose levels and support weight loss efforts. Carb Starver targets consumers and patients looking for non-systemic interventions for metabolic syndrome and type 2 diabetes.